Get the tools used by (smart)2 investors.

Dividend CAGR (3y) for Akebia Ther

Join now and get access to the full platform

Search for company or ETF

 

  0 results available. Select is focused ,type to refine list, press Down to open the menu,

AKBA: Akebia Ther

Akebia Therapeutics, Inc., a biopharmaceutical company, focuses on the development and commercialization of therapeutics for patients with kidney diseases. The company’s product portfolio includes Vaf...

1.91 USD
Price
USD
Fair Value
Upside
0.80 - 2.89
52-week range

Analysis

Fiscal Years
Trailing Twelve Months
Fiscal Halfs
Fiscal Quarters
Daily
Hide this widget

The following section summarizes insights on Akebia Ther's Dividend CAGR (3y):

AKBAHLTH.USFGENARDXAMGNNTLAPRME4.0%5.0%6.0%7.0%8.0%9.0%

Performance Summary
  • Dividend cagr (3y) for Akebia Ther is not meaningful. While computing the change, we detected that the latest value is negative, making the calculation not meaningful.

How does Akebia Ther's Dividend CAGR (3y) benchmark against competitors?

Hide this widget

We've identified the following companies as similar to Akebia Ther because they operate in a related industry or sector. We also considered size, growth, and various financial metrics to narrow down the list to the ones listed below.

Metric Usage: Dividend CAGR (3y)

Hide this widget
div_share_cagr_3y
Slug
number
Datatype
%.%
Format
current
Default Period
Premium
Plan

Data is returned as a standard number. Suggested format is percent (e.g 0.171 => 17.1%). Please note, you need a Premium subscription to access data for div_share_cagr_3y.

To view the full list of supported financial metrics please see Complete Metrics Listing.

Similar Metrics

Hide this widget

Metrics similar to Dividend CAGR (3y) in the dividends category include:

View Full List

Search for metric or datapoint

Dividend CAGR (3y)

Three-year compound annual growth rate in dividend per share.

Definition of Dividend CAGR (3y)

Sector Benchmark Analysis

All rights reserved. Terms Of Use